Back in early 2018, Aurora Cannabis (NYSE: ACB) became the shining star of the then high-flying marijuana industry in Canada. Having returned over 2,400% in a span of two years, the company produced many millionaire investors — but with a caveat.
For those who weren’t lucky enough to cash out and decided to hold on, Aurora shares are now down over 95% from all-time highs. Recently, the company has reignited investor interest with its aggressive cost-cutting measures and U.S. expansion. Has Aurora turned around its operations, and could it make its shareholders wealthy again?